Papel da óxido nítrico sintase induzível no córtex cerebral de modelos experimentais da acidemia metilmalônica

• Ano de defesa: 2012
• Autor(a) principal: Ribeiro, Leandro Rodrigo
• Tipo de documento: Tese
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal de Santa Maria; BR; Bioquímica; UFSM; Programa de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica
• Palavras-chave em Português: Óxido nítrico sintase induzível; Acidemia metilmalônica; Metilmalonato; Córtex cerebral; Convulsão; Neuroinflamação; Iinducible nitric oxide synthase; Methylmalonic acidemia; Methylmalonate; Cerebral cortex; Convulsion; Neuroinflammation; CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA
• Link de acesso: http://repositorio.ufsm.br/handle/1/4464

Methylmalonic acidemia is an inborn error of metabolism characterized clinically and biochemically by tissue accumulation of methylmalonic acid (MMA) and neurological dysfunction, including convulsion. Furthermore, clinical data suggest that infections conditions can precipitate metabolic crisis and cause neurological changes observed in patients of acidemia. Provided that the MMA cause neurological complications, and that the inflammation can contribute to the occurrence of convulsions and cognitive deficit in several animal models, it is possible to suggest that inflammatory mediators, such as inducible nitric oxide synthase (iNOS), facilitate MMA-induced convulsions. The iNOS is one of three isoforms of nitric oxide synthase (NOS), which generates nitric oxide (NO), a simple gaseous signaling molecule and free radical. The iNOS is induced at injury/inflammation sites, but is also constitutively expressed on some cells, such as in neurons. Studies in experimental models have already demonstrated that NO generated in the central nervous system (CNS), by endothelial and neuronal isoforms of NOS, is involved in MMA-induced convulsions. However, until the present moment are scarce the data in the literature evaluating the relationship of iNOS in experimental models of Methylmalonic Acidemia. The results published in the article has shown that iNOS knock-out C57BL/6 mice, when injected acutely with MMA (2 μmols/2 μl, intracerebroventricularly), have a shorter duration of seizures, no significant change in the mean amplitude of electroencephalographic waves (EEG); not increase the levels of nitrite and nitrate (NOx) compared to animals injected with saline, but have a partial reduction in the levels of 3-nitrotyrosine (3-NT) compared to wild animals that were also treated with MMA; similarly, show a partially lower inhibition of Na+,K+-ATPase, but exhibit no difference in succinate dehydrogenase (SDH) inhibition on cerebral cortex compared to wild mice which also received MMA. The results submitted in the manuscript has shown that Wistar rats, after being injected chronically with MMA (from 5th to 28th day of life, twice daily, with doses ranging from 0.76 to 1.67 mmol/g depending on the age of the animal, via subcutaneous) showed a reduced index of recognition in spatial learning/memory test, but show no anxiety at elevated plus maze test; they have a reduction in neutrophils, but an increase in the number of mononuclear leukocytes in the blood; and in addition show increased levels of interleukin-1beta (IL-1β), tumor necrosis factor-alpha (TNF-α), iNOS and 3-NT in the cerebral cortex. Considering the data presented in both studies, it was concluded that the MMA can cause seizures, nitrosative stress and inhibition of Na+,K+-ATPase activity in cerebral cortex of mice by mechanisms related to NO production via iNOS; and that the MMA can also cause neurocognitive deficits, altered immune system in blood and increase of pro-inflammatory cytokines, leading to increased expression of iNOS and nitrosative stress.